Fostemsavir: A Novel Attachment Inhibitor for Patients With Multidrug-Resistant HIV-1 Infection.

Published in: The Annals of pharmacotherapy (2020)

FTR provides an alternative agent when composing a regimen for patients with multidrug-resistant HIV-1 infection. It is generally well tolerated, with few significant interactions, and neither renal nor hepatic dose adjustments are required.

Keyphrases

multidrug resistant
drug resistant
antiretroviral therapy
gram negative
acinetobacter baumannii
klebsiella pneumoniae
cystic fibrosis